1. Home
  2. AMCX vs QTTB Comparison

AMCX vs QTTB Comparison

Compare AMCX & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

N/A

Current Price

$10.83

Market Cap

492.0M

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$8.32

Market Cap

450.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMCX
QTTB
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.0M
450.1M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
AMCX
QTTB
Price
$10.83
$8.32
Analyst Decision
Sell
Strong Buy
Analyst Count
8
6
Target Price
$9.83
★ $39.60
AVG Volume (30 Days)
558.5K
★ 827.2K
Earning Date
11-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
132.55
★ 136.78
EPS
★ N/A
N/A
Revenue
★ $2,311,801,000.00
$53,737,000.00
Revenue This Year
$5.07
N/A
Revenue Next Year
N/A
$150.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.47
$1.91
52 Week High
$12.93
$23.57

Technical Indicators

Market Signals
Indicator
AMCX
QTTB
Relative Strength Index (RSI) 36.47 30.86
Support Level $9.13 $5.12
Resistance Level $11.13 $16.85
Average True Range (ATR) 0.36 0.70
MACD -0.12 0.07
Stochastic Oscillator 10.99 22.26

Price Performance

Historical Comparison
AMCX
QTTB

About AMCX AMC Networks Inc.

AMC Global Media owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: